Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations

Movement Disorders

Volumn 23, Issue 13, 2008, Pages 1812-1819

  Schneider, Susanne A ^a   Talelli, Penelope ^a   Cheeran, Binith J ^a   Khan, Naheed L ^a   Wood, Nicholas W ^a   Rothwell, John C ^a   Bhatia, Kailash P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Carrier asymptomatic; Neurophysiology; Parkin; Parkinson's disease Parkinsonism; TMS

Indexed keywords

6 FLUORODOPA F 18; DOPAMINE RECEPTOR STIMULATING AGENT; PARKIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FACILITATION; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; MOTOR NERVE CONDUCTION; NERVE EXCITABILITY; NEUROPHYSIOLOGICAL RECRUITMENT; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PYRAMIDAL TRACT; SYMPTOMATOLOGY; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; MUTATION; NEURAL CONDUCTION; PARKINSON DISEASE; PYRAMIDAL TRACTS; REACTION TIME; RECRUITMENT, NEUROPHYSIOLOGICAL; SENSORY THRESHOLDS; TRANSCRANIAL MAGNETIC STIMULATION; UBIQUITIN-PROTEIN LIGASES;

EID: 57049153993     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22025     Document Type: Article

References (31)

1. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608.
2. Nisipeanu P, Inzelberg R, Abo MS, et al. Parkin gene causing benign autosomal recessive juvenile parkinsonism. Neurology 2001;56:1573-1575.
3. Yamamura Y, Hattori N, Matsumine H, Kuzuhara S, Mizuno Y. Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification. Brain Dev 2000;22 (Suppl 1):S87-S91.
4. Khan NL, Katzenschlager R, Watt H, et al. Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology 2004;62:1224-1226.
5. Hayashi S, Wakabayashi K, Ishikawa A, et al. An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. Mov Disord 2000;15:884-888.
6. Mori H, Kondo T, Yokochi M, et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 1998;51:890-892.
7. Klein C, Pramstaller PP, Kis B, et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol 2000;48:65-71.
8. Rawal N, Periquet M, Lohmann E, et al. New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism. Neurology 2003;60:1378-1381.
9. Abbas N, Lucking CB, Ricard S, et al. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's disease genetics study group and the European consortium on genetic susceptibility in Parkinson's disease. Hum Mol Genet 1999;8:567-574.
10. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's disease genetics study group. N Engl J Med 2000;342:1560-1567.
11. West AB, Lockhart PJ, O'Farell C, Farrer MJ. Identification of a novel gene linked to parkin via a bi-directional promoter. J Mol Biol 2003;326:11-19.
12. Hedrich K, Eskelson C, Wilmot B J, et al. Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord 2004;19:1146-1157.
13. Hilker R, Klein C, Hedrich KK, et al. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans. Neurosci Lett 2002;323:50-54.
14. Khan NL, Scherfler C, Graham E, et al. Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology 2005;64:134-136.
15. Cantello R, Tarletti R, Civardi C. Transcranial magnetic stimulation and Parkinson's disease. Brain Res Brain Res Rev 2002;38: 309-327.
16. De Rosa A, Volpe G, Marcantonio L, et al. Neurophysiological evidence of corticospinal tract abnormality in patients with parkin mutations. J Neurol 2006;253:275-279.
17. Baumer T, Pramstaller PP, Siebner H, et al. Sensorimotor integration is abnormal in asymptomatic parkin mutation carriers - a TMS study. Neurology 2007;69:1976-1981.
18. Di Lazarro V, Oliviero A, Saturno E, et al. Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 2005;564:661-668.
19. Edwards MJ, Huang YZ, Mir P, Rothwell JC, Bhatia KP. Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers. Mov Disord 2006;21:2181-2186.
20. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain 2003;126:1279-1292.
21. Rothwell JC. Techniques and mechanisms of action of transcranial stimulation of the human motor cortex. J Neurosci Methods 1997;74:113-122.
22. Orth M, Rothwell JC. The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse. Clin Neurophysiol 2004;115:1076-1082.
23. Terao Y, Ugawa Y. Basic mechanisms of TMS. J Clin Neurophysiol 2002;19:322-343.
24. Rothwell JC. Physiological studies of electric and magnetic stimulation of the human brain. Electroencephalogr Clin Neurophysiol Suppl 1991;43:29-35.
25. Abbruzzese G, Marchese R, Trompetto C. Sensory and motor evoked potentials in multiple system atrophy: a comparative study with Parkinson's disease. Mov Disord 1997;12:315-321.
26. Cantello R. Applications of transcranial magnetic stimulation in movement disorders. J Clin Neurophysiol 2002;19:272-273.
27. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995;37:181-188.
28. Buhmann C, Binkofski F, Klein C, et al. Motor reorganization in asymptomatic carriers of a single mutant parkin allele: a human model for presymptomatic parkinsonism. Brain 2005;128:2281-2290.
29. Kujirai T, Caramia MD, Rothwell JC, et al. Corticocortical inhibition in human motor cortex. J Physiol London 1993;471:501-519.
30. Talelli P, Greenwood RJ, Rothwell JC. Arm function after stroke: neurophysiological correlates and recovery mechanisms assessed by transcranial magnetic stimulation. Clin Neurophysiol 2006;117:1641-1659.
31. Kujirai K, Kujirai T, Sinkjaer T, Rothwell JC. Associative plasticity in human motor cortex during voluntary muscle contraction. J Neurophysiol 2006;96:1337-1346.